Addex Therapeutics Ltd
ADDXF
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.78M
Close$
Share Statistics
| Market cap | $3.78 Million |
|---|---|
| Enterprise Value | $3.09 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -358.96% |
|---|---|
| Return on Assets | -196.79% |
| Return on Invested Capital | -216.30% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 16.27 |
| Enterprise Value to EBIT | -0.68 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Addex Therapeutics Ltd
27 employees
CEO: Tim Dyer Addex Therapeutics Ltd is a biopharmaceutical firm based in Switzerland, dedicated to identifying, developing, and commercializing small-molecule pharmaceutical products designed to address central nervous system (CNS) disorders. The com...